bone mets

A Brief Update of the Current Landscape of Bone Targeted Therapies for Prostate Cancer

Prostate cancer tends to metastasize to bones as opposed to soft tissue and other organs. We have no idea why it does have a preference for bone, but it does. Developing bone metastases in prostrate cancer is a very strong negative prognostic indicator. Prostate cancer’s tendency to favor bone over soft tissue causes significant morbidity [...]

By Malecare|2016-10-14T13:14:25-04:00October 14th, 2016|Advanced Prostate Cancer, Alpharadin (radium-223), bisphosphonates, Bone Metastases, Bones and Prostate Cancer, Drugs & Treatments, Survival, Uncategorized, Understanding Advanced Prostate Cancer, Xgeva, Xofigo, Zometa|2 Comments

Factors Pointing to the Development of Metastatic Prostate Cancer

It is inevitable; most men with prostate cancer, who require treatment with androgen deprivation therapy (ADT), will eventually become resistance to treatment leading to the development of metastatic disease. Men who develop metastatic castrate-resistant disease have a very poor prognosis. Historically, their overall survival is estimated only to be 24 to 36 months. A study [...]

By Malecare|2017-10-19T10:54:35-04:00September 4th, 2009|Advanced Prostate Cancer, General Information, Hormone Therapy, Metastases, Research, Uncategorized, Understanding APC|0 Comments